Search Results
Search for other papers by R Nawar in
Google Scholar
PubMed
Search for other papers by D Aron in
Google Scholar
PubMed
the use of serum molecular markers A variety of tissue molecular markers, including mutant p53, the proliferation-associated antigen ki67 protein, and loss of heterozygocity at the 17p13 and 11p15 loci, have been used to distinguish malignant
Search for other papers by T Jardé in
Google Scholar
PubMed
Search for other papers by F Caldefie-Chézet in
Google Scholar
PubMed
Search for other papers by N Goncalves-Mendes in
Google Scholar
PubMed
Search for other papers by F Mishellany in
Google Scholar
PubMed
Search for other papers by C Buechler in
Google Scholar
PubMed
Search for other papers by F Penault-Llorca in
Google Scholar
PubMed
Université Clermont 1, Centre Jean-Perrin, Université de Regensburg, Centre Jean-Perrin, UFR Pharmacie, EA4233, CLARA, CRNH-A, 63001 Clermont-Ferrand, France
Search for other papers by M P Vasson in
Google Scholar
PubMed
both on breast cancer cell proliferation, on the adiponectin and leptin pathways, and on the expression of molecular markers used to diagnose and gauge prognosis of breast cancer. Materials and methods Clinical study on breast cancer biopsies Breast
Department of Diabetology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Marc Diedisheim in
Google Scholar
PubMed
Department of Gastroenterology and Digestive Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Solène Dermine in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Search for other papers by Amandine Septier in
Google Scholar
PubMed
Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Sébastien Gaujoux in
Google Scholar
PubMed
Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Bertrand Dousset in
Google Scholar
PubMed
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Department of Diabetology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Etienne Larger in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Search for other papers by Raphael Scharfmann in
Google Scholar
PubMed
Department of Pathology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Benoit Terris in
Google Scholar
PubMed
Department of Gastroenterology and Digestive Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Romain Coriat in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
genomic tools ( International Cancer Genome Consortium et al. 2010 , Weinstein et al. 2013 ). This effort transformed our understanding of cancer and provided molecular markers which are now included in clinical routine. This effort is still ongoing
Search for other papers by H E Jones in
Google Scholar
PubMed
Search for other papers by J M W Gee in
Google Scholar
PubMed
Search for other papers by K M Taylor in
Google Scholar
PubMed
Search for other papers by D Barrow in
Google Scholar
PubMed
Search for other papers by H D Williams in
Google Scholar
PubMed
Search for other papers by M Rubini in
Google Scholar
PubMed
Search for other papers by R I Nicholson in
Google Scholar
PubMed
improving efficacy and duration of response in a greater number of patients but additionally, delineate other molecular markers which may predict sensitivity to EGFR inhibitors such as gefitinib. Characteristics of acquired resistance to
Search for other papers by Theodoros Foukakis in
Google Scholar
PubMed
Search for other papers by Arief Gusnanto in
Google Scholar
PubMed
Search for other papers by Amy YM Au in
Google Scholar
PubMed
Search for other papers by Anders Höög in
Google Scholar
PubMed
Search for other papers by Weng-Onn Lui in
Google Scholar
PubMed
Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Search for other papers by Göran Wallin in
Google Scholar
PubMed
Search for other papers by Jan Zedenius in
Google Scholar
PubMed
-treatment of benign lesions. In the current study, 26 potential molecular markers were evaluated by qRT-PCR in a panel of 75 follicular tumors that covered the entire clinical spectrum, from innocent FTAs, borderline AFTAs and MI-FTCs, to pernicious WI
Search for other papers by Maria Rosaria Sapio in
Google Scholar
PubMed
Search for other papers by Anna Guerra in
Google Scholar
PubMed
Search for other papers by Daniela Posca in
Google Scholar
PubMed
Search for other papers by Paolo Piero Limone in
Google Scholar
PubMed
Search for other papers by Maurilio Deandrea in
Google Scholar
PubMed
Search for other papers by Manuela Motta in
Google Scholar
PubMed
Search for other papers by Giancarlo Troncone in
Google Scholar
PubMed
Search for other papers by Alessia Caleo in
Google Scholar
PubMed
Search for other papers by Pasquale Vallefuoco in
Google Scholar
PubMed
Department of Endocrinologia ed Oncologia Molecolare e Clinica, ASO Ordine Mauriziano di Torino,, Biologia e Patologia Cellulare e Molecolare,, Institute of Endocrinologia ed Oncologia Sperimentale ‘G Salvatore’,, Università Federico II, Via S. Panini, 5, Naples 80131 Italy
Search for other papers by Guido Rossi in
Google Scholar
PubMed
Search for other papers by Gianfranco Fenzi in
Google Scholar
PubMed
Search for other papers by Mario Vitale in
Google Scholar
PubMed
, Barroeta et al . 2006 , Nakamura et al . 2006 , Rossi et al . 2006 ). More recently, the identification of oncogenes with pathogenetic role in the mechanism of thyroid cell transformation has provided new molecular markers of PTC. The thymine
Search for other papers by Teresa M Seccia in
Google Scholar
PubMed
Search for other papers by Ambrogio Fassina in
Google Scholar
PubMed
Search for other papers by Gastone G Nussdorfer in
Google Scholar
PubMed
Search for other papers by Achille C Pessina in
Google Scholar
PubMed
Search for other papers by Gian Paolo Rossi in
Google Scholar
PubMed
even on morphological grounds. Although several criteria have been claimed to allow discrimination between benign and malignant tumors ( Lack 1997 ), including some molecular markers such as the DNA index ( Suzuki et al. 1992 b , Gicquel & Le Bouc
Search for other papers by William R Doerfler in
Google Scholar
PubMed
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Elena M Morariu in
Google Scholar
PubMed
Search for other papers by N Paul Ohori in
Google Scholar
PubMed
Search for other papers by Simion I Chiosea in
Google Scholar
PubMed
Search for other papers by Michael S Landau in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Division of Endocrinology, University of Texas Medical Branch, Galveston, Texas, USA
Search for other papers by Pooja Manroa in
Google Scholar
PubMed
testing is being increasingly used in thyroid nodules with indeterminate cytology, including Hürthle cell nodules, to assist in the management of these patients ( Patel et al. 2018 , Steward et al. 2019 ). However, how the molecular markers of Hürthle
Search for other papers by Patricia de Cremoux in
Google Scholar
PubMed
Search for other papers by Dan Rosenberg in
Google Scholar
PubMed
Search for other papers by Jacques Goussard in
Google Scholar
PubMed
Search for other papers by Catherine Brémont-Weil in
Google Scholar
PubMed
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Search for other papers by Frédérique Tissier in
Google Scholar
PubMed
Search for other papers by Carine Tran-Perennou in
Google Scholar
PubMed
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Search for other papers by Lionnel Groussin in
Google Scholar
PubMed
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Search for other papers by Xavier Bertagna in
Google Scholar
PubMed
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Unité de Pharmacologie, Ecole Nationale Vétérinaire d'Alfort, Laboratoire d'Oncobiologie, Department of Pathology, Department of Endocrinology, Department of Endocrinology, Faculté de Médecine Paris-Ile de France Ouest, INSERM, Département d'Endocrinologie Métabolisme and Cancer, CNRS, Faculté de Médecine René Descartes, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
classification, Weiss criteria, and molecular markers ( Macfarlane 1958 , Weiss et al . 1989 , Gicquel et al . 2001 ). Three normal adrenal samples, consisting of tissue adjacent to an adrenal cyst or another non-secreting benign tumor, were also studied
Department of Clinical Medical Sciences, Seoul National University, College of Medicine, Seoul, Republic of Korea
Search for other papers by Kwon Joong Na in
Google Scholar
PubMed
Cheonan Public Health Center, Chungnam, Republic of Korea
Search for other papers by Hongyoon Choi in
Google Scholar
PubMed
’s multiple testing corrections. Expression of immunosuppressive molecular markers, CTLA-4, PD-L1 and HLA-G, was statistically compared according to TDS and the BRAF V600E mutation status. The correlation between TDS and immunosuppressive markers was